Xu et al.57 reported that EIF3B gene expression can accelerate the progression of esophageal squamous cell carcinoma by activating β-catenin signaling, which can promote immune escape and resistance to anti-PD-1 therapy41. This evidence concerns the gene EIF3B and esophageal squamous cell carcinoma.